84911-45-5

Upstream product

• 917-54-4 methyllithium 
• 76236-32-3 2,3-dideoxy-5-O-(triphenylmethyl)-D-glycero-pent-2-enono-1,4-lactone 
• 76-83-5 trityl chloride 
• 84911-43-3 (3R,4S,5R)-3,4-dihydroxy-5-(trityloxymethyl)-dihydrofuran-2(3H)-one 
• 84911-44-4 2,3-O-(thiocarbonyl)-5-O-(triphenylmethyl)-D-ribono-1,4-lactone 
• 5336-08-3 D-Ribono-1,4-lactone 
• 81480-31-1 (S)-(-)-4-methyl-5-trityloxymethyl-2(5H)-furanone 
• 76236-31-2 (S)-3-Phenylselanyl-5-trityloxymethyl-dihydro-furan-2-one 
• 73968-62-4 (5S)-5-[(trityloxy)methyl]tetrahydro-2-furanone 
• 81474-42-2 (-)-3-carboxy-4-(1-hydroxy-2-trityloxyethyl)-1-pyrazoline γ-lactone 

Downstream Products

• 53798-51-9 Verrucarinsaeure, α,δ-Dihydroxy-β-methyl-valeriansaeure 

Relevant academic research and scientific papers

A synthetic route to 3-C-alkyl (or 3-C-phenyl-) 2,3-dideoxy-D-erythro- pentono-1,4-lactones: Intermediates in the synthesis of 2(3H)-furanones

A series of 3-C-alkyl- (and 3-C-phenyl-) 2,3-dideoxy-D-erythro-pentono- 1,4-lactones, compounds which are important in the synthesis of modified nucleosides and antibiotic sugars, were synthesized from D-ribonolactone. By a route that proceeded via 5-O-pr

SYNTHETIC APPROACHES TOWARD VERRUCARIN A. CHIRAL SYNTHESIS OF (-)-VERRUCARINOLACTONE

(-)-Verrucarinolactone ((2S,3R)-2,5-dihydroxy-3-methylvaleric acid δ-lactone) (4) was synthesized stereoselectively from an optically active butyrolactone ((S)-γ-trityloxymethyl-γ-butyrolactone) (6) as a chiral synthon.